All Stories

  1. The Prevalence of Potentially Inappropriate Medications (PIMs) Among Frail Older Participants of The Irish Longitudinal Study on Ageing (TILDA)
  2. 230 Inter-rater reliability assessment of OPTI-3S (criteria for optimising medicines by stopping, stepping down, or switching to safer alternatives)
  3. 229 OPTI-3S (criteria for optimising medicines by stopping, stepping down, or switching to safer alternatives): consensus validation via a Delphi method
  4. 182 Pharmacists’ opinions on deprescribing Fall Risk Increasing Drugs in older people
  5. Deprescribing Medications that Increase the Risk of Falls in Older People: Exploring Doctors' Perspectives Using the Theoretical Domains Framework (TDF)
  6. 115 BARRIERS AND FACILITATORS TO DOCTORS DEPRESCRIBING FALL-RISK INCREASING DRUGS IN OLDER ADULTS
  7. 237 POTENTIALLY INAPPROPRIATE PRESCRIBING IN HOSPITALISED FRAIL OLDER ADULTS: DEVELOPMENT OF THE OPTI-3S PRELIMINARY STATEMENTS
  8. 173 SYSTEMATIC REVIEW-BASED FINDINGS TO GUIDE THE DEVELOPMENT AND REPORTING OF CONSENSUS-BASED CRITERIA FOR INAPPROPRIATE PRESCRIBING IN OLDER ADULTS
  9. Design and implementation of online patient-facing experiences for an integrated pharmacy programme
  10. Development of Professional Attributes through Integration of Science and Practice at First-Year Pharmacy Level
  11. Personalized Biofeedback on Inhaler Adherence and Technique by Community Pharmacists: A Cluster Randomized Clinical Trial
  12. 113 Pharmacist Interventions at Discharge and the Quality of Older Patients' Care: A Systematic Review
  13. Design and Implementation of an Integrated Competency-Focused Pharmacy Programme: A Case Report
  14. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy
  15. Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy
  16. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy
  17. A Method to Calculate Adherence to Inhaled Therapy that Reflects the Changes in Clinical Features of Asthma
  18. Irregular and Ineffective: A Quantitative Observational Study of the Time and Technique of Inhaler Use
  19. The effect of providing feedback on inhaler technique and adherence from an electronic audio recording device, INCA®, in a community pharmacy setting: study protocol for a randomised controlled trial
  20. Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity
  21. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences
  22. Teicoplanin usage in adult patients with haematological malignancy in the UK and Ireland: Is there scope for improvement?
  23. Tumour vasculature targeting agents in hybrid/conjugate drugs
  24. How can hospitals become safer?
  25. Oral Session 2
  26. Profiling harmful medication errors in an acute Irish teaching hospital
  27. ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011
  28. Isosorbide-2-benzyl Carbamate-5-salicylate, A Peripheral Anionic Site Binding Subnanomolar Selective Butyrylcholinesterase Inhibitor
  29. Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability
  30. Measuring and benchmarking safety culture: application of the safety attitudes questionnaire to an acute medical admissions unit
  31. Isosorbide-2-carbamate Esters: Potent and Selective Butyrylcholinesterase Inhibitors
  32. Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitor
  33. Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase
  34. Why do some community pharmacists supply methadone to drug misusers while others do not?
  35. N1-Dansyl-spermine: a potent polyamine antagonist
  36. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog